Recent Company News

• 07:36 PM ET Jul 02, 2026
  

  DEP milestone triggers Radiopharm A$0.5M option fee to Starpharma Holdings (A$0.71, 0.00)

• 07:31 PM ET Jul 01, 2026
  

  Starpharma Holdings notes preclinical data for DEP HER2-Lu shows favourable biodistribution and encouraging anti-tumour activity (A$0.71, 0.00)

• 09:42 PM ET May 14, 2026
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 06:32 PM ET Jun 16, 2026
  

  Ajava holdings discloses 6.13% holding in Starpharma Holdings - Form 603 (A$0.69, 0.00)